No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ALVO Alvotech
- 13.640
- -0.210-1.52%
Close Jun 18 16:00 ET
3.81BMarket Cap-6557P/E (TTM)
13.810High13.400Low154.33KVolume13.800Open13.850Pre Close2.10MTurnover0.18%Turnover RatioLossP/E (Static)279.57MShares18.00052wk High-5.79P/B1.19BFloat Cap6.70052wk Low--Dividend TTM87.07MShs Float18.000Historical High--Div YieldTTM2.96%Amplitude5.200Historical Low13.604Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Alvotech SA - Agreement Covers European Economic Area, UK, Switzerland, Canada, Australia, and New Zealand
Express News | Alvotech SA- Advanz Pharma Will Be Responsible for Registration and Commercialization
Express News | Alvotech SA- Alvotech Will Be Responsible for Development and Commercial Supply of Avt06 and Avt29
Express News | Reg-Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® Ld/Hd in Europe
Express News | Alvotech SA May Offer And Sell Ordinary Shares Of Up To $75M From Time To Time; Entered Into Open Market Sale Agreement With Jefferies Relating To Sale Of Ordinary Shares
Express News | Alvotech SA - Entered Into Open Market Sale Agreement With Jefferies LLC Relating to Sale of Ordinary Shares
Comments
Citi analysts are hopeful that Alvotech will lead the market with its interchangeable high-dose Humira biosimilar, despite the FDA's recent rejection of the AVT04 biosimilar and anticipate a February 2025 launch.
$Alvotech(ALVO.US$ shell buy volta for 169 M. 0.86 per share
$Alvotech(ALVO.US$ Dont missed out. Medicare will enforced insurance to use biosimolar / generic rather than branded costly meds for auto immune medication as long as its patent is expiring.
$Alvotech(ALVO.US$ january 20 closing in Biosimilar
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg